Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib with Chemoradiotherapy for Locally Advanced NSCLC
NCT04182698Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in non-small cell lung cancer (NSCLC), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
anlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04182698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04182698.